Natural antisense transcript to Actin alpha 1, skeletal muscle

This molecule is a natural antisense transcript (NAT) that is complementary to the *Actin alpha 1, skeletal muscle* (ACTA1) gene transcript. NATs are a class of non-coding RNAs found in eukaryotic genomes that regulate gene expression through several potential mechanisms, including RNA masking, transcriptional interference, chromatin modification, and RNA duplex formation[2][3]. NATs can influence the expression of their corresponding sense gene (here, ACTA1), but the majority are not protein-coding and are not established therapeutic targets. The biological roles of most NATs are still emerging; in some cases, they modulate chromatin or RNA stability and can act in epigenetic regulation[1][2][3]. There is no direct evidence that the antisense transcript to ACTA1 is a disease gene, drug target, or biomarker at this time. Key points: - This entry is a non-coding RNA, not a therapeutically targeted protein or receptor. - The role of the antisense transcript to ACTA1 is presumed regulatory; there is no current evidence for a direct disease or therapeutic relevance. - NATs like this may regulate muscle genes at the epigenetic or transcriptomic level but are not currently drug targets or disease biomarkers[2][3]. - Treat this as a transcriptional regulatory RNA, not as a classical druggable target.

Other names

Antisense to ACTA1ENSG00000290037